< Back to companies
Tempus

Tempus

AI-powered precision medicine company using clinical, molecular, and multimodal data to support diagnostics, treatment selection, and life sciences research.

Get Involved in Tempus

How We Help

Why it matters

Tempus is one of the most scaled examples of AI-plus-diagnostics infrastructure, combining clinical molecular testing, data libraries, and life sciences monetization.

Products

📦

Tempus xT CDx

Next-generation sequencing companion diagnostic platform for oncology.

Learn more →
📦

Tempus multimodal data platform

Clinical and molecular data library and analytics platform for precision medicine and life sciences.

Learn more →

What the company reports

Claims are attributed to their source and not independently verified unless noted.

  • Tempus describes itself as building one of the world's largest libraries of clinical and molecular data.

    Company statessource →
  • Tempus AI trades on Nasdaq under ticker TEM.

    Per Digital.Healthsource →
  • Reuters reported Tempus sought up to a $6.1B valuation in its 2024 IPO.

    Company statessource →

Core Technology

AI, Genomic Testing, Multimodal Data, Clinical Decision Support, Data Platform

Company Info

Business Model
Diagnostics, Data Platform, Life Sciences Partnerships
Website
www.tempus.com/

MedStartr Index Score

?
10

What do you think of Tempus?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Tempus